Learning objectives:

• Discuss the background of iron deficiency and iron deficiency anemia, and their associated co-morbidities
• Introduce a novel oral iron formulation that addresses many of the current limitations associated with oral iron products
• Review and discuss available clinical data on ferric maltol

Speaker:

Dr. Connie Ha, PharmD, is a Medical Science Liaison at Shield Therapeutics.  Connie is a clinical pharmacist by training, she graduated from USC School of Pharmacy in 2004 and subsequently completed her residency in Pharmacy Practice at Kaiser Permanente Santa Clara.  After her residency, she stayed on board at Kaiser Permanente as an ambulatory care pharmacist and managed a number of patients with chronic diseases before joining the pharmaceutical industry.  Prior to her role at Shield, Connie has over 14 years of industry experience which include a wide range of therapeutic areas such as cardiovascular and metabolic diseases, infectious disease, pain management, gastroenterology, nephrology, and rare disease.  When not working, Connie enjoys spending time with her 3-year-old son.